Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 110-121 , April 2010

Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors

  • Hatem A. Azim Jr.

      Affiliations

    • Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
    • Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium
    • Corresponding Author InformationCorresponding author. Address: 55 Abdel Monem Riad Street, Mohandeseen, Cairo, Egypt. Tel.: +20 2 33026814; fax: +20 2 33028656.
    • ,
  • Nicholas Pavlidis

      Affiliations

    • Department of Medical Oncology, Ioannina University, Ioannina, Greece
    • ,
  • Fedro A. Peccatori

      Affiliations

    • Department of Medicine, Division of Hematology–Oncology, European Institute of Oncology, Milan, Italy

Received 11 September 2009 ,Revised 9 November 2009 ,Accepted 15 November 2009.

References 

  1. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7:279–287
  2. Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006;42:126–140
  3. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5:283–291
  4. Abellar RG, Pepperell JR, Greco D, Gundogan F, Kostadinov S, Schwartz J, et al. Effects of chemotherapy during pregnancy on the placenta. Pediatr Dev Pathol. 2009;12:35–41
  5. Russell MA, Carpenter MW, Akhtar MS, Lagattuta TF, Egorin MJ. Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk. J Perinatol. 2007;27:241–243
  6. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics, 2009. CA Cancer J Clin. 2009;59:225–249
  7. Connors JM. State-of-the-art therapeutics: Hodgkin’s lymphoma. J Clin Oncol. 2005;23:6400–6408
  8. Jameel A, Jamil SN. Safety of cytotoxic chemotherapy during pregnancy. J Pak Med Assoc. 2007;57:449–452
  9. De Carolis S, Grimolizzi F, Garofalo S, Fatigante G, Ferrazzani S, Carducci B, et al. Cancer in pregnancy: results of a series of 32 patients. Anticancer Res. 2006;26:2413–2418
  10. Fadilah SA, Leong CF, Jamil MY, Cheong SK, Rozilaila R. Pregnancy complicated by Hodgkin’s disease. Med J Malaysia. 2006;61:358–360
  11. Dilek I, Topcu N, Demir C, Bay A, Uzun K, Gul A, et al. Hematological malignancy and pregnancy: a single-institution experience of 21 cases. Clin Lab Haematol. 2006;28:170–176
  12. Schäffer M, Hegenbart U, Klostermann K, Stepan H. Hodgkin’s disease in pregnancy-case report and literature review. Z Geburtshilfe Neonatol. 2003;207:71–73
  13. Peres RM, Sanseverino MT, Guimaraes JL, Coser V, Giuliani L, Moreira RK, et al. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res. 2001;34:1551–1559
  14. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2:173–177
  15. Klepfish A, Schattner A, Shtalrid M, Shvidel L, Berrebi A, Bentwich Z. Advanced Hodgkin’s disease in a pregnant HIV seropositive woman: favorable mother and baby outcome following combined anticancer and antiretroviral therapy. Am J Hematol. 2000;63:57–58
  16. Anselmo AP, Cavalieri E, Enrici RM, Pescarmona E, Guerrisi V, Paesano R, et al. Hodgkin’s disease during pregnancy: diagnostic and therapeutic management. Fetal Diagn Ther. 1999;14:102–105
  17. Okechukwu CN, Ross J. Hodgkin’s lymphoma in a pregnant patient with acquired immunodeficiency syndrome. Clin Oncol (R Coll Radiol). 1998;10:410–411
  18. Ferrari VD, Jirillo A, Lonardi F, Pavanato G, Bonciarelli G. Pregnancy during alpha-interferon therapy in patients with advanced Hodgkin’s disease. Eur J Cancer. 1995;31A:2121–2122
  19. Wiebe VJ, Sipila PE. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol. 1994;16:75–112
  20. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med. 1992;152:573–576
  21. Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and foetal outcome following Hodgkin’s disease in pregnancy. Br J Caner. 1992;65:114–117
  22. Zauzu J, Julia A, Sierra J, Valentin MG, Coma A, Sanz MA, et al. Pregnancy outcome in hematologic malignancies. Cancer. 1991;67:703–709
  23. Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH. Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer. 1987;60:1143–1150
  24. Nisce LZ, Tome MA, He S, Lee BJ, Kutcher GJ. Management of coexisting Hodgkin’s disease and pregnancy. Am J Clin Oncol. 1986;9:146–151
  25. Wiesner-Bornstein R, Niesen M, Grobe-Einsler R, Schulte-Hotley M. Chemotherapy for Hodgkin’s disease during pregnancy-case report. Geburtshilfe Frauenheilkd. 1983;43:373–376
  26. D’Incalci M, Sessa C, Colombo N, de Palo G, Semprini AE, Pardi G. Transplacental passage of cyclophosphamide. Cancer Treat Rep. 1982;66:1681–1682
  27. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the pregnant patient with Hodgkin’s disease. Ann Intern Med. 1981;95:669–675
  28. Daly H, McCann SR, Hanratty TD, Temperley IJ. Successful pregnancy during combination chemotherapy for Hodgkin’s disease. Acta Haematol. 1980;64:154–156
  29. Blatt J, Mulvihill JJ, Ziegler JL, Young RC, Poplack DG. Pregnancy outcome following cancer chemotherapy. Am J Med. 1980;69:828–832
  30. Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy. Haematologica. 2007;92:1230–1237
  31. Mazonakis M, Varveris H, Fasoulaki M, Damilakis J. Radiotherapy of Hodgkin’s disease in early pregnancy: embryo dose measurements. Radiother Oncol. 2003;66:333–339
  32. Woo SY, Fuller LM, Cundiff JH, Bondy ML, Hagemeister FB, MacLaughlin P, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin’s disease. Int J Radiat ONcol Biol Phys. 1992;23:407–412
  33. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6:328–333
  34. Cordeiro A, Machado AI, Borges A, Alves MJ, Frade MJ. Burkitt’s lymphoma related to Epistein-Barr virus infection during pregnancy. Arch Gynecol Obstet. 2009;280:297–300
  35. Rey J, Coso D, Roger V, Bouayed N, Belmecheri N, Ivanov V, et al. Rituximab combined with chemotherapy for lymphoma during pregnancy. Leuk Res. 2009;33:e8–e9
  36. Soliman KB, Abbas MM, Seksaka MA, Wafa S, Balah AS. Aggressive primary thyroid non-Hodgkin’s lymphoma with pregnancy. Saudi Med J. 2007;28:634–636
  37. Ataergin S, Kanat O, Arpaci F, Ozet A. A rare occurrence of diffuse lymphoblastic lymphoma in pregnancy. Am J Hematol. 2007;82:173–174
  38. Lam MS. Treatment of Burkitt’s lymphoma during pregnancy. Ann Pharmacother. 2006;40:2048–2052
  39. Decker M, Rothermundt C, Holländer G, Tichelli A, Rochlitz C. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol. 2006;7:693–694
  40. Magloire LK, Pettker CM, Buhimschi CS, Funai EF. Burkitt’s lymphoma of the ovary in pregnancy. Obstet Gynecol. 2006;108:743–745
  41. Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N. The effects of rituximab treatment during pregnancy on a neonate. Haematologica. 2006;91:1426–1427
  42. Kimby E, Sverrisdottir A, Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol. 2004;72:292–295
  43. Reimer P, Rüdiger T, Müller J, Rose C, Wilhelm M, Weissinger F. Subcutaneous panniculitis-like-T-cell lymphoma during pregnancy with successful autologous stem cell transplantation. Ann Hematol. 2003;82:305–309
  44. Echols KT, Gilles JM, Diro M. Mycosis fungoides in pregnancy: remission after treatment with alpha-interferon in a case refractory to conventional therapy: a case report. J Matern Fetal Med. 2001;10:68–70
  45. Herold M, Schnohr S, Bittrich H. Efficacy and safety of combined rituximab chemotherapy during pregnancy. J Clin Oncol. 2001;19:3439
  46. Garcia L, Valcarcel M, Santiago-Borrero PJ. Chemotherapy during pregnancy and its effects on the fetus-neonatal myelosuppression: two case reports. J Perinatol. 1999;19:230–233
  47. Mavrommatis CG, Daskalakis GJ, Papageorgiou IS, Antsaklis AJ, Michalas SK. Non-Hodgkin’s lymphoma during pregnancy – case report. Eur J Obstet Gynecol Reprod Biol. 1998;79:95–97
  48. Rodriguez JM, Haggag M. VACOP-B chemotherapy for high grade non-Hodgkin’s lymphoma in pregnancy. Clin Oncl (R Coll Radiol). 1995;7:319–320
  49. Goldwasser F, Pico JL, Cerrina J, Fernandez H, Pons JC, Cosset JM, et al. Successful chemotherapy including epirubicin in a pregnant non-Hodgkin’s lymphoma patient. Leuk Lymphoma. 1995;20:173–176
  50. Lishner M, Zemlickis D, Sutcliffe SB, Koren G. Non-Hodgkin’s lymphoma and pregnancy. Leuk Lymphoma. 1994;14:411–413
  51. Moore DT, Taslimi MM. Multi-agent chemotherapy in a case of non-Hodgkin’s lymphoma in second trimester of pregnancy. J Tenn Med Assoc. 1991;84:435–436
  52. Lambert J, Wijermans PW, Dekker GA, Ossenkoppele GJ. Chemotherapy in non-Hodgkin’s lymphoma during pregnancy. Neth J Med. 1991;38:80–85
  53. Toki H, Okabe K, Kamei H, Shimokawa T, Hiura M, Kondo M, et al. Successful chemotherapy in a pregnant non-Hodgkin’s lymphoma patient. Acta Med Okayama. 1990;44:321–323
  54. Nantel S, Parboosingh J, Poon MC. Treatment of an aggressive non-Hodgkin’s lymphoma during pregnancy with MACOP-B chemotherapy. Med Pediatr Oncol. 1990;18:143–145
  55. du Bois A, Runge M, Schmid J, Hillemanns HG. Disseminated highly malignant non-Hodgkin’s lymphoma and pregnancy: polychemotherapy in the 2d and 3d trimester. Geburtshilfe Frauenheilkd. 1990;50:405–409
  56. Ba-Thike K, Oo N. Non-Hodgkin’s lymphoma in pregnancy. Asia Oceania J Obstet Gynaecol. 1990;16:229–232
  57. Garg A, Kochupillai V. Non-Hodgkin’s lymphoma in pregnancy. South Med J. 1985;78:1263–1264
  58. Schapira DV, Chudley AE. Successful pregnancy following continuous treatment with combination chemotherapy before conception and through pregnancy. Cancer. 1984;54:800–803
  59. Karp GI, von Oeyen P, Valone F, Khetarpal VK, Israel M, Mayer RJ, et al. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep. 1983;67:773–777
  60. Berrebi A, Schattner A, Mogilner BM. Disseminated Burkitt’s lymphoma during pregnancy. Acta Haematol. 1983;70:139–140
  61. Lowenthal RM, Funnell CF, Hope DM, Stewart IG, Humphrey DC. Normal infants after combination chemotherapy including teniposide for Burkitt’s lymphoma in pregnancy. Med Pediatr Oncol. 1982;10:165–169
  62. Garcia V, Miguel JS, Borrasca AL. Doxorubicin in the first trimester of pregnancy. Ann Intern Med. 1981;94:547
  63. Falkson HC, Simson IW, Falkson G. Non-Hodgkin’s lymphoma in pregnancy. Cancer. 1980;45:1679–1682
  64. Azim HA, Santoro L, Bociek RG, Gandini S, Malek RA, Azim HA HA. High dose intensity doxorubicin in aggressive non-Hodgkin’s lymphoma: a literature-based meta-analysis. Ann Oncol. 2009;
  65. Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification f lymphoid neoplasms: the microscope as a tool for disease recovery. Blood. 2008;112:4384–4399
  66. Di Bella N, Ravandi F. Purine analogue combinations for indolent lymphomas. Semin Hematol 2006;43(2 Suppl 2):S11–21.
  67. Baumgärtner AK, Oberhoffer R, Jacobs VR, Ostermayer E, Menzel H, Voigt M, et al. Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML. Onkologie. 2009;32:40–43
  68. Coiffier B. Monoclonal antibody as therapy for malignant lymphomas. CR Biol. 2006;329:241–254
  69. Cortes J. Natural history and staging of chronic myelogenous leukemia. Hematol Oncol Clin North Am. 2004;18:569–584
  70. de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myeloid leukemia. Nature. 1982;300:765–767
  71. Druker BJ, Guilhot F, O’Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408–2417
  72. Cortes J, O’Brien S, Kantarjian H. Discontinuation of imatinib therapy after achieving a molecular response. Blood. 2004;104:2204–2205
  73. Investigators brochure, STI571 (formerly CGP 57148B), and data on file, Novartis pharma AG, Basel, Switzerland.
  74. Hutchings G, Gevaert T, Deprest J, Nilius B, De Ridder D. Effect of prolonged c-kit receptor inhibition by imatinib mesylate on the uterine contractility of pregnant rabbits. Gynecol Obstet Invest. 2008;65:108–111
  75. Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, et al. The effects of imatinib on pregnancy outcome. Blood. 2008;111:5505–5508
  76. Dolai TK, Bhargava R, Mahapatra M, Mishra P, Seth T, Pati HP, et al. Is imatinib safe during pregnancy?. Leuk Res. 2009;33:572–573
  77. Ali R, Ozkalemkas F, Kimya Y, Koksal N, Ozkocaman V, Gulten T, et al. Imatinib use during pregnancy and breast feeding: a case report and review of the literature. Arch Gynecol Obstet. 2009;280:169–175
  78. Skoumalova I, Vondrakova J, Rohon P, Rozmanova S, Jarosova M, Indrak K, et al. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008;152:121–123
  79. Meera V, Jijina F, Shrikande M, Madkaikar M, Ghosh K. Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy. Leuk Res. 2008;32:1620–1622
  80. Buyukbayrak EE, Ergen B, Karsidag YK, Kars B, Turan C, Argon D. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report. Arch Gynecol Obstet. 2008;278:161–163
  81. Garderet L, Santacruz R, Barbu V, van den Akker J, Carbonne B, Gorin NC. Two successful pregnancies in a chronic myeloid leukemia patients treated with imatinib. Haematologica. 2007;92:e9–e10
  82. Yilmaz M, Demirhan O, Kuçukosmanoglu E, Pehlivan M, Okan V, Balat O, et al. Pregnancy in patients with chronic myeloid leukemia treated with imatinib. Leuk Lymphoma. 2007;48:2454–2456
  83. Suppiah R, Kalaycio M. Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester. Leuk Lymphoma. 2006;47:1149–1150
  84. Ault P, Kantarjian H, O’Brien S, Faderl S, Beran M, Rios MB, et al. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol. 2006;24:1204–1208
  85. Choudhary DR, Mishra P, Kumar R, Mahapatra M, Choudhry VP. Pregnancy on imatinib: fatal outcome with meningocele. Ann Oncol. 2006;17:178–179
  86. Ali R, Ozkalemkaş F, Ozçelik T, Ozkocaman V, Ozan U, Kimya Y, et al. Pregnancy under treatment of imatinib and successful labor in a patient wit chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib after achieving a molecular remission. Leuk Res. 2005;29:971–973
  87. Prabhash K, Sastry PS, Biswas G, Bakshi A, Prasad N, Menon H, et al. Pregnancy outcome of two patients treated with imatinib. Ann Oncol. 2005;16:1983–1984
  88. Alkindi S, Dennison D, Pathare A. Imatinib in pregnancy. Eur J Haematol. 2005;74:535–537
  89. Heartin E, Walkinshaw S, Clark RE. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib. Leuk Lymphoma. 2004;45:1307–1308
  90. Hensley ML, Ford JM. Imatinib treatment: specific issues related to safety, fertility, and pregnancy. Semin Hematol 2003;40(2 Suppl 2):21–5.
  91. Mughal TI, Goldman JM. Chronic myeloid leukemia: current status and controversies. Oncology (Williston Park). 2004;18:837–844
  92. Li D, Xu DZ, Choi BC, Men K, Zhang JX, Lei XY, et al. Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy. J Med Virol. 2005;76:203–207
  93. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev. 2004;202:8–32
  94. Regierer AC, Schulz CO, Kuehnhardt D, Flath B, Possinger K. Interferon-alpha therapy for chronic myeloid leukemia during pregnancy. Am J Hematol. 2006;81:149–150
  95. Mesquita MM, Pestana A, Mota A. Successful pregnancy occurring with interferon-alpha therapy in chronic myleoid leukemia. Acta Obstet Gynecol Scand. 2005;84:300–301
  96. Al Bahar S, Pandita R, Nath SV. Pregnancy in chronic myeloid leukemia patients treated with alpha interferon. Int J Gynaecol Obstet. 2004;85:281–282
  97. Mubarak AA, Kakil IR, Awidi A, Al-Homsi U, Fawzi Z, Kelta M, et al. Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: report of 3 cases and review of the literature. Am J Hematol. 2002;69:115–118
  98. Hiratsuka M, Minakami H, Koshizuka S, Sato I. Administration of interferon-α during pregnancy: effect on fetus. J Perinat Med. 2000;28:372–376
  99. Baykal C, Zengin N, Coşkun F, Güler N, Ayhan A. Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy: a case report. Eur J Gynaecol Oncol. 2000;21:80–90
  100. Kuroiwa M, Gondo H, Ashida K, Kamimura T, Miyamoto T, Niho Y, et al. Interferon-alpha therapy for chronic myelogenous leukemia during pregnancy. Am J Hematol. 1998;59:101–102
  101. Haggstrom J, Adriansson M, Hybbinette T, Harnby E, Thorbert G. Two cases of CML treated with alpha-interferon during second and third trimester of pregnancy with analysis of the drug in the new-born immediately postpartum. Eur J Haematol. 1996;57:101–102
  102. Baer MR, Ozer H, Foon KA. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol. 1992;81:167–169
  103. Reichel RP, Linkesch W, Schetitska D. Therapy with recombinant interferon alpha-2c during unexpected pregnancy in a patient with chronic myeloid leukaemia. Br J Haematol. 1992;82:472–473
  104. Crump M, Wang XH, Sermer M, Keating A. Successful pregnancy and delivery during alpha-interferon therapy fro chronic myeloid leukemia. Am J Hematol. 1992;40:238–239
  105. Frame D. Chronic myeloid leukemia: standard treatment options. Am J Health Syst Pharm 2006;63(23 Suppl 8):S10–4.
  106. Chaube S, Murphy ML. The effects of hydroxyurea and related compounds on the rat foetus. Cancer Res. 1996;20:1448–1457
  107. Millicovsky G, Desesso JM, Kleiman L, Clark K. Effects of hydroxyurea on hemodynamics of pregnant rabbits: a maternally mediated mechanism of embryotoxicity. Am J Obst Gynecol. 1981;140:747–752
  108. Fadilah SA, Ahmad-Zailani H, Soon-Keng C, Norlaila M. Successful treatment of chronic myeloid leukemia during pregnancy with hydroxyurea. Leukemia. 2002;16:1202–1203
  109. Thauvin-Robinet C, Maingueneau C, Robert E, Elefant E, Guy H, Caillot D, et al. Exposure to hydroxyurea during pregnancy: a case series. Leukemia. 2001;15:1309–1311
  110. Celiloglu M, Altunyurt S, Undar B. Hydroxyurea treatment for chronic myeloid leukemia during pregnancy. Acta Obstet Gynecol Scand. 2000;79:803–804
  111. Szanto F, Kovacs L. Successful delivery following continuous cytostatic therapy of leukemic pregnant women. Orv Hetil. 1993;134:527–529
  112. Fitzgerald JM, McCann SR. The combination of hydroxyurea and leucapharesis in the treatment of chronic myeloid leukemia in pregnancy. Clin Lab Hematol. 1993;15:63–65
  113. Jackson N, Shukri A, Ali K. Hydroxyurea treatment for chronic myeloid leukemia during pregnancy. Br J Haematol. 1993;85:203–204
  114. Tertian G, Tchernia G, Papiernik E, Elefant E. Hydroxyurea and pregnancy. Am J Obstet Gynecol. 1992;166:1868
  115. Delmer A, Rio B, Bauduer F, Ajchenbaum F, Marie JP, Zittoun R. Pregnancy during mylesuppressive treatment fro chronic myelegenous leukemia. Br J Haematol. 1992;81:167–169
  116. Patel M, Dukes IA, Hull JC. Use of hydroxyurea in chronic myeloid leukemia during pregnancy: a case report. Am J Obstet Gynecol. 1991;165:565–566
  117. Williams SF, Bitran JD. Cancer and pregnancy. Clin Perinatol. 1985;12:609–623
  118. Norhaya MR, Cheong SK, Hamidah NH, Ainoon O. Pregnancy in a patient receiving busulphan for chronic myeloid leukemia. Singapore Med J. 1994;35:102–103
  119. Aviles A, Diaz-mangueo JC, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol. 1991;36:243–248
  120. Juárez S, Cuadrado Pastor JM, Feliu J, González Barón M, Ordóñez A, et al. Association of leukemia and pregnancy: clinical and obstetrics aspects. Am J Clin Oncol. 1988;11:159–165
  121. Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev. 2008;22:247–259
  122. Ferrara F, Palmieri S, Leoni F. Clinically useful prognostic factors in acute myeloid leukemia. Crit Rev Oncol Hematol. 2008;66:181–193
  123. Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol. 1987;5:1098–1106
  124. Niedermeier DM, Frei-Lahr DA, Hall PD. Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Pharmacotherapy. 2005;25:1134–1140
  125. Matsuo K, Shimoya K, Ueda S, Wada K, Koyama M, Murata Y. Idarbicin administered during pregnancy: its effects on the fetus. Gynecol Obstet Invest. 2004;58:186–188
  126. Yucebilgin MS, Cagirgan S, Donmex A, Ozkinay E, Akercan F, Mgoyi L, et al. Acute myeloblastic leukemia in pregnancy: a case report and review of the literature. Eur J Gynaecol Oncol. 2004;25:126–128
  127. Ali R, Ozkalemkaş F, Ozçelik T, Ozkocaman V, Ozan U, Kimya Y, et al. Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. Leuk Res. 2003;27:381–385
  128. Greenlund LJ, Letendre L, Tefferi A. Acute leukemia during pregnancy. A single institutional experience with 17 cases. Leuk Lymphoma. 2001;41:571–577
  129. Partridge AH, Garber JE. Long-term outcomes of children exposed to antineoplastic agents in utero. Semin Oncol. 2000;27:712–726
  130. Claahsen HL, Semmekrot BA, van Dongen PW, Mattijssen V. Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy – a case report. Am J Perinatol. 1998;15:295–297
  131. Veneri D, Todeschini G, Pizzolo G, Franchini M, Ambrosetti A, Vassanelli A, et al. Acute leukemia and pregnancy. Case report. Clin Exp Obstet Gynecol. 1996;23:112–115
  132. Cavenagh JD, Richardson DS, Cahill MR, Bernard T, Kelsey SM, Newland AC. Treatment of acute myeloid leukemia in pregnancy. Lancet. 1995;346:441–442
  133. Hsu KF, Chang CH, Chou CY. Sinusoidal fetal heart-rate pattern during chemotherapy in a pregnant woman with acute myelogenous leukemia. J Formos Med Assoc. 1995;94:562–565
  134. Morshita S, Imai A, Kawabata I, Tamaya T. Acute myleogenous leukemia in pregnancy: fetal blood sampling and early effects of chemotherapy. Int J Gynaecol Obstet. 1994;44:273–277
  135. Al-Bahar S, Pandita R. Twin pregnancy with acute myeloblastic leukemia: successful obstetric and hematological outcome. Ann Saudi Med. 1994;14:68–69
  136. Reynoso EE, Huerta F. Acute leukemia and pregnancy—fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol. 1994;33:709–710
  137. Artlich A, Möller J, Tschakaloff A, Schwinger E, Kruse K, Gortner L. Teratogenic effects in a case of maternal treatment for acute myelocytic leukemia—neonatal and infantile course. Eur J Pediatr. 1994;153:488–491
  138. Gondo H, Hamasaki Y, Nakayama H, Kondo T, Mitsuuchi J, Kawaga Y, et al. Acute leukemia during pregnancy. Association with immune-mediated thrombocytopenia in mother and infant. Acta Haematol. 1990;83:140–144
  139. Roy V, Gutteridge CN, Nysenbaum A, Newland AC. Combination chemotherapy with conservative obstetric management in the treatment of pregnant patients with acute myeloblastic leukaemia. Clin Lab Haematol. 1989;11:171–178
  140. Feliu J, Juarez S, Ordoñez A, Garcia-Paredes ML, Gonzalez-Baron M, Montero JM. Acute leukemia and pregnancy. Cancer. 1988;61:580–584
  141. Volkenandt M, Büchner T, Hiddemann W, Van de Loo J. Acute leukaemia during pregnancy. Lancet. 1987;2:1521–1522
  142. Fassas A, Kartalis G, Klearchou N, Tsatalas K, Sinacos Z, Mantalenakis S. Chemotherapy for acute leukemia during pregnancy: five case reports. Nouv Rev Fr Hematol. 1984;26:19–24
  143. Cantini E, Yanes B. Acute myleogenous leukemia in pregnancy. South Med J. 1984;77:1050–1052
  144. Awidi AS, Tarawneh MS, Shubair KS, Issa AA, Dajani YF. Acute leukemia in pregnancy: report of five cases treated with a combination which included a low dose of adriamycin. Eur J Cancer Clin Oncol. 1983;19:881–884
  145. Plows CW. Acute myelomonocytic leukemia in pregnancy: report of a case. Am J Obstet Gynecol. 1982;143:41–43
  146. de Souza JJ, Bezwada WR, Jetham D, Sonnendecker EW. Acute leukemia in pregnancy. A case report and discussion on modern management. S Afr Med J. 1982;62:295–296
  147. Taylor G, Blom J. Acute leukemia during pregnancy. South Med J. 1980;73:1314–1315
  148. Tobias JS, Bloom HJ. Doxorubicin in pregnancy. Lancet. 1980;1:776
  149. Schafer AI. Teratogenic effects of antileukemic chemotherapy. Arch Intern Med. 1981;141:514–515
  150. Pizzuto J, Aviles A, Noriega L, Niz J, Morales M, Romero F. Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat Rep. 1980;64:679–683
  151. Colbert N, Najman A, Gorin NC, Blum F, Treisser A, Lasfargues G, et al. Acute leukaemia during pregnancy: favourable course of pregnancy in two patients with cytosine arabinoside and anthracyclines. Nouv Presse Med. 1980;9:175–178
  152. A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. AML Collaborative Group. Br J Haematol 1998;103:100–9.
  153. Rohatiner AZ, Bassan R, Raimondi R, Amess JA, Arnott S, Personen A, et al. High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukemia. Ann Oncol. 2000;11:1007–1015
  154. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219–1226
  155. Molkenboer JF, Vos AH, Schouten HC, Vos MC. Acute lymphoblastic leukaemia in pregnancy. Neth J Med. 2005;63:361–363
  156. Bergstrom SK, Altman AJ. Pregnancy during therapy for childhood acute lymphoblastic leukemia: two case reports and a review of the literature. J Pediatr Hematol Oncol. 1998;20:154–159
  157. Wagner VM, Hill JS, Weaver D, Baehner RL. Congenital abnormalities in baby born to cytarabine treated mother. Lancet. 1980;2:98–99
  158. Ali R, Ozkalemkas F, Kimya Y, Koksal N, Ozkan H, Ozkocaman V, et al. Acute leukemia and pregnancy. Leuk Res. 2009;33:e26–e28
  159. Papantoniou N, Daskalakis G, Marinopoulos S, Anastasakis E, Mesogitis S, Antsaklis A. Management of pregnancy in adolescence complicated by acute lymphoblastic leukemia. Fetal Diagn Ther. 2008;23:164–167
  160. Hansen WF, Fretz P, Hunter SK, Yankowitz J. Leukemia in pregnancy and fetal response to multiagent chemotherapy. Obstet Gynecol. 2001;97:809–812
  161. Camera A, Campanile M, Catalano D, Mattace Raso A, Rotoli B. Relapse of acute lymphoblastic leukemia during pregnancy. Eur J Gynaecol Oncol. 1996;17:303–305
  162. Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. AM J Obstet Gynecol. 2000;183:511–512
  163. Peccatori FA, Azim HA, Scarfone G, Gadducci A, Bonazzi C, Gentilini O, et al. Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat. 2009;115:591–594
  164. Karp GI, von Oeyen P, Valone F, Khetarpal VK, Israel M, Mayer RJ, et al. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep. 1983;67:773–777
  165. Dara P, Slater LM, Armentrout SA. Successful pregnancy during chemotherapy for acute leukemia. Cancer. 1981;47:845–846
  166. Douer D. The epidemiology of acute promyelocytic leukaemia. Best Pract Res Clin Haematol. 2003;16:357–367
  167. Uchiumi H, Matsushima T, Yamane A, Doki N, Irisawa H, Saitoh T, et al. Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Int J Hematol. 2007;86:137–142
  168. Degos L, Wang ZY. All trans retinoic acid in acute promyelocytic leukemia. Oncogene. 2001;20:7140–7145
  169. Valappil S, Kurkar M, Howell R. Outcome of pregnancy in women treated with all-trans retinoic acid; a case report and review of literature. Hematology. 2007;12:415–418
  170. Consoli U, Figuera A, Milone G, Meli CR, Guido G, Indelicato F, et al. Acute promyelocytic leukemia during pregnancy: report of 3 cases. Int J Hematol. 2004;79:31–36
  171. Itoh M, Takao S, Yago K, Shimada H. Successful treatment of acute promyelocytic leukemia in a pregnant patient with all-trans retinoic acid and chemotherapy resulting in a safe delivery. Rinsho Ketsueki. 2003;44:401–403
  172. Carradice D, Austin N, Bayston K, Ganly PS. Successful treatment of acute promyelocytic leukaemia during pregnancy. Clin Lab Haematol. 2002;24:307–311
  173. Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer. 2002;12:399–402
  174. Fadilah SA, Hatta AZ, Keng CS, Jamil MA, Singh S. Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid. Leukemia. 2001;15:1665–1666
  175. Giagounidis AA, Beckmann MW, Giagounidis AS, Aivado M, Emde T, Germing U, et al. Acute promyelocytic leukemia and pregnancy. Eur J Haematol. 2000;64:267–271
  176. Maeda M, Tyugu H, Okubo T, Yamamoto M, Nakamura K, Dan K. A neonate born to a mother with acute promyelocytic leukemia treated by all-trans retinoic acid. Rinsho Ketsueki. 1997;38:770–775
  177. Incerpi MH, Miller DA, Posen R, Byrne JD. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy. Obstet Gynecol. 1997;89:826–828
  178. Terada Y, Shindo T, Endoh A, Watanabe M, Fukaya T, Yajima A. Fetal arrhythmia during treatment of pregnancy-associated acute promyelocytic leukemia with all-trans retinoic acid and favorable outcome. Leukemia. 1997;11:454–455
  179. Sham RL. All-trans retinoic acid-induced labor in a pregnant patient with acute promyelocytic leukemia. Am J Hematol. 1996;53:145
  180. Lin CP, Huang MJ, Liu HJ, Chang IY, Tsai CH. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah’s Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin. Am J Hematol. 1996;51:251–252
  181. Lipovsky MM, Biesma DH, Christiaens GC, Petersen EJ. Successful treatment of acute promyelocytic leukaemia with all-trans-retinoic-acid during late pregnancy. Br J Haematol. 1996;94:699–701
  182. Simone MD, Stasi R, Venditti A, Del Poeta G, Aronica G, Bruno A, et al. All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia. Leukemia. 1995;9:1412–1413
  183. Nakamura K, Dan K, Iwakiri R, Gomi S, Nomura T. Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid. Ann Hematol. 1995;71:263–264
  184. Watanabe R, Okamoto S, Moriki T, Kizaki M, Kawai Y, Ikeda Y. Treatment of acute promyelocytic leukemia with all-trans retinoic acid during the third trimester of pregnancy. Am J Hematol. 1995;48:210–211
  185. Tsuda H, Doi H, Inada T, Shirono K. Successful treatment of acute promyelocytic leukemia in a pregnant woman by using all-trans retinoic acid. Rinsho Ketsueki. 1994;35:717–719
  186. Harrison P, Chipping P, Fothergill GA. Successful use of all-trans retinoic acid in acute promyelocytic leukaemia presenting during the second trimester of pregnancy. Br J Haematol. 1994;86:681–682
  187. Stentoft J, Nielsen JL, Hvidman LE. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy. Leukemia. 1994;8:1585–1588
  188. Van Maldergem L, Jauniaux E, Gillerot Y. Morphological features of a case of retinoic acid embryopathy. Prenat Diagn. 1992;12:699–701
  189. García L, Valcárcel M, Santiago-Borrero PJ. Chemotherapy during pregnancy and its effects on the fetus—neonatal myleosuppression: two case reports. J Perinatol. 1999;19:230–233
  190. Requena A, Velasco JG, Pinilla J, Gonzalez-Gonzalez A. Acute leukemia during pregnancy: obstetric management and perinatal outcome of two cases. Eur J Obstet Gynecol Reprod Biol. 1995;63:139–141
  191. Hoffman MA, Wiernik PH, Kleiner GJ. Acute promyelocytic leukemia and pregnancy. A case report. Cancer. 1995;76:2237–2241
  192. Takatsuki H, Abe Y, Goto T, Sadamura S, Taguchi F, Muta K, et al. Two cases of acute promyelocytic leukemia in pregnancy and the effect of anthracyclines on fetal development. Rinsho Ketsueki. 1992;33:1736–1740
  193. Wallace PJ. Complete remission in acute promyelocytic leukemia despite the persistence of the 15, 17 translocation. Am J Hematol. 1989;31:266–268
  194. D’Emilio A, Dragone P, De Negri G, Montaldi A, Stella M, Battista R. Acute myleogenous leukemia in pregnancy. Haematologica. 1989;74:601–604
  195. Bartsch HH, Meyer D, Teichmann AT, Speer CP. Treatment of promyelocytic leukemia during pregnancy. A case report and review of the literature. Blut. 1988;57:51–54
  196. Catanzarite VA, Ferguson JE. Acute leukemia and pregnancy: a review of management and outcome. 1972–1982. Obstet Gynecol Surv. 1984;39:663–678
  197. Sanz MA, Rafecas FJ. Successful pregnancy during chemotherapy for acute promyelocytic leukemia. N Engl J Med. 1982;306:939
  198. Alegre A, Chunchurreta R, Rodriguez-Alarcon J, Cruz E, Prada M. Successful pregnancy in acute promyelocytic leukemia. Cancer. 1982;49:152–153
  199. Robak T. Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treat Rev. 2006;32:365–376
  200. Gürman G. Pregnancy and successful labor in the course of chronic lymphocytic leukemia. Am J Hematol. 2002;71:208–210
  201. Welsh TM, Thompson J, Lim S. Chronic lymphocytic leukemia in pregnancy. Leukemia. 2000;14:1155
  202. Chrisomalis L, Baxi LV, Heller D. Chronic lymphocytic leukemia in pregnancy. Am J Obstet Gynecol. 1996;175:1381–1382
  203. Ali R, Ozkalemkas F, Kimya Y, Koksal N, Ozkocaman V, Yorulmaz H, et al. Pregnancy in chronic lymphatic leukemia: experience with fetal exposure to chlorambucil. Leuk Res. 2009;33:567–569
  204. Ghosh A, Ayers KJ. Darbepoetin alfa for treatment of anaemia in a case of chronic renal failure during pregnancy-case report. Clin Exp Obstet Gynecol. 2007;34:193–194
  205. Sobilo-Jarek L, Popowska-Drojecka J, Muszytowski M, Wani-Kossowska M, Kobelski M, Czekalski S. Anemia treatment with darbepoetin alpha in pregnant female with chronic renal failure: report of two cases. Adv Med Sci. 2006;51:309–311
  206. Sackmann Massa F, Pavlovsky S. Myelodysplastic syndrome and pregnancy: case report. Leuk Res. 2009;33:e23–e25
  207. Dhanjal MK, Mitrou S. The obstetric care of the pregnant woman with cancer. Recent Results Cancer Res. 2008;178:195–201
  208. Nahum GG, Uhl K, Kennedy DL. Antibiotics use in pregnancy and lactation: what is and is not known about teratogenic and toxic effects. Obstet Gynecol. 2006;107:1120–1138
  209. Ishikawa M, Soma A, Takada H, Mizukami A, Kitamura S, Shimizu T. Study of imipenem.cilastin sodium in the perinatal period. Jpn J Antibiot. 1988;41:1742–1750
  210. Chimura T, Murayama K, Oda T, Igarashi Y, Morisaki N, Hirayama , et al. Clinical effects of meropenem on infectious diseases in obstetrics and gynecology. Jpn J Antibiot. 2001;54:1–7
  211. Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med. 1988;319:1617–1623
  212. New York State Department of Health. Congenital Malformation Registry 1995 – annual Report.

PII: S0305-7372(09)00178-9

doi: 10.1016/j.ctrv.2009.11.004

Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 110-121 , April 2010

Article Tools